Navigation Links
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Date:9/3/2007

Ranbaxy will benefit from the 180 day shared exclusivity on the product

PRINCETON, N.J., Aug. 30 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the Company has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Galantamine Hydrobromide Tablets, 4mg (base), 8mg (base), and 12mg (base). Galantamine is indicated for the treatment of mild to moderate dementia of the Alzheimer's type. Total annual market sales for Razadyne were $130.0 million (IMS - MAT: June 2007).

"This tentative approval will provide Ranbaxy Pharmaceuticals Inc. (RPI) with an opportunity to market this product and anticipate sharing in the period of 180 days exclusivity that will be beneficial to the Company, as well as to the U.S. healthcare system. We will launch the product upon final approval, which is anticipated on December 14, 2008. At the time of launch, product will be available immediately to all classes of trade," according to Jim Meehan, Vice President of Sales and Distribution for RPI.

Ranbaxy Pharmaceuticals Inc. (RPI) based in Jacksonville, Florida, USA, is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company. RPI is engaged in the sale and distribution of generic and branded prescription products in the U.S. healthcare system.

Ranbaxy Laboratories Limited, India's largest pharmaceutical company, headquartered in India, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in developed markets and significant progress in New Drug Discovery Research. The Company's foray into Novel Drug Delivery Systems has led to proprietary "platform technologies," resulting in a number of products under development. The Company is serving
'/>"/>

SOURCE Ranbaxy Pharmaceuticals Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. RANBAXY - enters anti-AIDS segment
2. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
3. Ranbaxy gets US FDA approval for Lisinopril
4. Ranbaxy Labs Entry Into Anti-Acne Market
5. Ranbaxy trying to make inroads in herbal drugs market
6. Lamivudine Manufactured By Ranbaxy gets the nod from the US FDA
7. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
8. Ranbaxy opens Drug discovery centre in Gurgaon
9. Ranbaxy Laboratories All Set To Export Bird Flu Vaccines
10. Ranbaxy Gets USFDA Approval For Doxycycline Tablets
11. SRL Ranbaxy offers quicker bird flu diagnostic test

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...nderstanding Brain Wiring and Diseases ,, WASHI...my Schmahmann, Professor of Neurology at Harvard M... General Hospital in Boston, on Thursday, November...w field of study called "Connectivity" at the laun...n is an award-winning leader in the field of the c...
(Date:11/20/2009).../ -- Following a recall by Unilever The Stop &...s Country Crock ® Side Dishes DELUXE Cheddar ...e Dishes DELUXE Four Cheese Pasta due to an undecl...ates and UPCs are affected: ,, Shedd,s Country...Rice 21 oz, UPC 027400218316, Best By NOV 29 09 th...
(Date:11/20/2009)...FirstCall/ -- Centene Corporation (NYSE: CNC )...of America Merrill Lynch 2009 Credit Conference, t...Hotel Times Square in New York City. ,, Centene... Eastern Time. Investors and other interested part...presentation at: http://www.veracast.com/webcasts...
(Date:11/20/2009)...-FirstCall/ -- SIRIUS XM Radio (Nasdaq: SIRI ) ...dio Reports: What Every Women Needs to Know About...n journalist Perri Peltz. ,, (Logo: http://ww...,, Doctor Radio Reports: What Every Woman Ne...21 live at 10:00 am ET on Doctor Radio , SIRIUS c...
(Date:11/20/2009)...gency medical service (EMS) providers in the Unite...ts each year. Only 5 to 10 percent of people who ...y cardiopulmonary resuscitation (CPR) provided by ...etter patient outcome. The Resuscitation Outcomes... network to study prehospital treatments for cardi...
Breaking Medicine News(10 mins):Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 2Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 3Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 4Health News:SIRIUS XM to Broadcast 'Doctor Radio Reports: What Every Woman Needs To Know About Mammograms' 5Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 2Health News:Effect of real-time CPR feedback reported at resuscitation science symposium 3
...Pa., March 3 The Quigley,Corporation (Nasdaq: QG...r,the fourth quarter ended December 31, 2007, comp... in 2006. For the year ended December 31, 2007,net...sales,decrease for the Company,s Cold Remedy segme...
...ation to list shares on American Stock Exchange, ...l/ -- China Sky One,Medical, Inc. (OTC Bulletin Bo...cturer, marketer and distributor of pharmaceutical...ng, Jiang Qi,Feng, Zhao Jie and Qian Xu Feng. As a...
...Pa., March 3 The Quigley,Corporation (Nasdaq: QG...completed the sale of it wholly owned subsidiary, ...s health and wellness products through its wholly,... terms of the agreement include a cash purchase pr...
...ed Pain Management Expert Robin Downing, DVM, Will... Aspects Related to Pain and Pets, DENVER, March ...ive webcast for veterinarians on pain management f...e,veterinarian, including common pain issues, over...
...ent and Health & Beauty Get a New Jolt with Java, ...,popular online destination that helps solve peopl...o" instruction on diverse topics, celebrates the,w...oThings.com has created a Caffeine Resource Guide ...
... March 3 The American Cancer Society, (http://www...reness Month aiding,people in preventing the onset... Institute, "153,760 new Colon and Rectal Cancer c...on Cancer or detect,tumors earlier than in the pas...
Other Medicine News:Health News:The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 2Health News:The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 3Health News:The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 4Health News:The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 5Health News:The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 6Health News:The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 7Health News:The Quigley Corporation Reports Fourth Quarter & 2007 Annual Results; Increases Investment to $6.5 million in Pharmaceutical R&D in 2007 8Health News:China Sky One Medical, Inc. Appoints Four Independent Board Members 2Health News:China Sky One Medical, Inc. Appoints Four Independent Board Members 3Health News:China Sky One Medical, Inc. Appoints Four Independent Board Members 4Health News:The Quigley Corporation Announces Sale of Its Health and Wellness Segment 2Health News:The Quigley Corporation Announces Sale of Its Health and Wellness Segment 3Health News:Pain Management For Pets, Key Strategies For Veterinarians - Live Webcast to Veterinarians, March 13, 7:00 p.m. to 8:00 p.m. (EDT) Via Morris Animal Foundation 2Health News:HowToDoThings.com Brews Up New Uses for Coffee That Will Perk You Up in Recognition of March's 'Caffeine Awareness Month' 2Health News:SGV Medical Supplies: 'Colostomy Supplies Easier to Obtain for the Colon Cancer Survivor' 2
(Date:11/20/2009)...irstCall/ -- Medco Health Solutions, Inc (NYSE: ... American healthcare through an advanced, wired ph...quality clinical care and fundamentally bending th...or the benefit of patients and payors alike. ,,...ts strategy enable "Smarter Medicine" to help addr...
(Date:11/20/2009)...re/ -- Reportlinker.com announces that a new marke..., Pipettes & Pipettors - A Global Market P...164373/Pipettes--Pipettors---A-Global-Market-Persp...r&utm_campaign=prnewswire ,, Pipettes and...research laboratory. Large-scale applications in l...
(Date:11/20/2009)...re/ -- Reportlinker.com announces that a new marke..., Medical Adhesives and Sealants - A US Market...242/Medical-Adhesives-and-Sealants---A-US-Market-R...&utm_campaign=prnewswire ,, The use of me...e in medical devices and equipments. Cutting edge ...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 2Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 3Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 4Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 5Reportlinker Adds Medical Adhesives and Sealants - A US Market Review 6Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 1Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 2Sigma Aldrich to Present at the UBS Global Life Sciences Conference on Monday September 21 2009 14064 1Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 1Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 2Pelosi Remarks at Democratic Steering and Policy Committee Forum on Health Insurance Reform 57234 3
...07 - Clinical results from a,Phase II study presen...ciety (AHS) annual meeting showed that MK-0974, an...ide (CGRP),receptor antagonist, significantly impr...ompared to placebo, and the relief was,sustained t...ted in,the study. Responses specific to other meas...
... weeks achieved an SVR rate at,least comparable to...e favorable quality-of-life scores -, ROCKVILLE, M...Genome Sciences, Inc. today announced the top-line...uferon(R) (albinterferon alfa-2b),in combination w...otype 1 chronic hepatitis C. The Company expects t...
Other Medicine Technology:Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 2Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 3Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 4Merck's Investigational Migraine Treatment MK-0974 Significantly,Improved Migraine Pain on Several Efficacy Measures in a Phase II,Study 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 2Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 3Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 4Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 5Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 6Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 7Human Genome Sciences Announces Positive Final Results Of Phase 2b,Trial of Albuferon 8
Lumenis 950 Slit Lamp
Novus 3000 532 nm Laser System
Selecta Duo Photocoagulator Combination Laser
EnTrust Single Chamber ICD
Medicine Products: